Publications

5803 Results

SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma

Authors
A Algazi;M Othus;A Daud;R Lo;J Mehnert;T-G Truong;R Conry;K Kendra;G Doolittle;J Clark;M Messino;D Moore;C Lao;B Faller;R Govindarajan;A Harker-Murray;L Dreisbach;J Moon;K Grossmann;A Ribas
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
S1320

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Small Bowel Cancer Cohort

Authors
YK Chae;M Othus;SP Patel;M Zalupski;A Kasi;M Khalil;A Kalyan;B Polite;S Fenton;S Gurung;C McLeod;F Giles;HX Chen;E Sharon;E Mayerson;M Plets;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Salivary Gland Tumor Cohort

Authors
YK Chae;M Othus;SP Patel;J Ohr;F Worden;J Suga;A Naing;S Fenton;H Kang;S Gurung;C Mcleod;F Giles;HX Chen;E Sharon;E Mayerson;M Plets;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA)
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

Authors
J Unger;D Hershman;R Osarogiagbon;A Gothwal;S Anand;NA Dasari;M Overman;J Loree;K Raghav
Journal / Conference
American Association for Cancer Research (June 22, 2020, virtual meeting), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors
L Hurwitz;I Kulac;B Gumuskaya;J Baena-Del Valle;I Benedetti;F Pan;JO Liu;M Marrone;K Arnold;P Goodman;C Tangen;MS Lucia;IM Thompson;CG Drake;W Isaacs;W Nelson;A De Marzo;EA Platz
Journal / Conference
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Oct;13(10):853-862; Jun 24;canprevres.0450.2019. doi: 10.1158/1940-6207.CAPR-19-0450. Online ahead of print.
Year
2020
Research Committee(s)
Cancer Control
PMID
PMID32581009
PMC
PMC7541466
Study Number(s)
SWOG-9217

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Authors
M Roschewski;K Dunleavy;JS Abramson;BL Powell;B Link;P Patel;PJ Bierman;D Jagadeesh;S Parekh;S Nagpal;TE O'Brien;R Mitsuyasu;D Peace;PR Watson;R Battini;W Hanna;C Melani;AN Lucas;SM Steinberg;S Pittaluga;ES Jaffe;JW Friedberg;BS Kahl;R Little;NL Bartlett;M Finale;A Noy;WH Wilson
Journal / Conference
Journal of Clinical Oncology Aug 1;38(22):2519-2529; May 26;JCO2000303. doi: 10.1200/JCO.20.00303. Online ahead of print
Year
2020
Research Committee(s)
Lymphoma
PMID
PMID32453640
PMC
PMC7392744
Study Number(s)
CTSU/9177

A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated High-Risk Acute Promyelocytic Leukemia (SWOG S0535)

Authors
JE Lancet;AB Moseley;SE Coutre;DJ DeAngelo;M Othus;MS Tallman;MR Litzow;RS Komrokj;HP Erba;FR Appelbaum
Journal / Conference
Blood Advances Apr 28;4(8):1683-1689
Year
2020
Research Committee(s)
Leukemia
PMID
PMID32330241
PMC
PMC7189292
Study Number(s)
S0535

Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials [Research Letter]

Authors
J Unger;CD Blanke;M Leblanc;D Hershman
Journal / Conference
JAMA Network Open Jun 1;3(6):e2010651
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID32478845
PMC
PMC7265094

Genome-wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls From the PanScan and PanC4 Consortia

Authors
H Tang;L Jiang;R Stolzenberg-Solomon;A Arslan;L Beane Freeman;P Bracchi;P Goodman;D Albanes;C Fuchs;J Gaziano;I Thompson;H Risch;N Chatterjee;A Klein;D Li;P Kraft;P Wei
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention Sep;29(9):1784-1791; Jun 16;cebp.0275.2020. doi: 10.1158/1055-9965.EPI-20-0275. Online ahead of print.
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID32546605
PMC
PMC7483330
Study Number(s)
S0000, SWOG-9217

Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Response [Response to Letter to Editor]

Authors
S Patel;M Othus;YK Chae;R Kurzrock
Journal / Conference
Clinical Cancer Research May 15;26(10):2434
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID32414761
Study Number(s)
S1609